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Abstract 
Metadata are critical in epidemiological and public health research. However, a lack of biomedical metadata 
quality frameworks and limited awareness of the implications of poor quality metadata renders data analyses 
problematic. In this study, we created and evaluated a novel framework to assess metadata quality of 
epidemiological and public health research datasets. We performed a literature review and surveyed stakeholders to 
enhance our understanding of biomedical metadata quality assessment. The review identified 11 studies and nine 
quality dimensions; none of which were specifically aimed at biomedical metadata. 96 individuals completed the 
survey; of those who submitted data, most only assessed metadata quality sometimes, and eight did not at all. Our 
framework has four sections: a) general information; b) tools and technologies; c) usability; and d) management 
and curation. We evaluated the framework using three test cases and sought expert feedback. The framework can 
assess biomedical metadata quality systematically and robustly.   
Introduction 
Metadata describe the data and the process through which they were collected. The use of metadata standards 
promotes a systematic approach to describing metadata elements and their structure. Metadata support researchers in 
making robust inferences and quickening the process of translating research findings into recommendations for 
change in policy and practice.  
Metadata are handled by stakeholders in epidemiological and public health research across the stages of the research 
data lifecycle. For example, data sharing practices vary amongst researchers and access to good quality metadata 
inclusive of data models can help researchers to better understand the data1, 2. At the data integration and 
harmonization stages, metadata can provide contextual information which enables the semantic alignment of 
disparate biomedical datasets3. Having a robust and standardized approach to metadata markup can help better 
support the documenting of research studies4. The quality of metadata is critical in enabling discoverability, data 
sharing and reuse as they often provide the contextual information needed to understand how the data were, for 
example, collected and when. 
The inherent complexity and heterogeneity of clinical information can lead to difficulties when trying to process 
these data. Identifying and characterizing certain research datasets such as linked clinical data as potential additional 
data sources, remains a challenging aspect of epidemiological and public health research5. Metadata, in many 
instances, are not subject to the same level of the scrutiny as the research data to which they are associated. 
Inconsistencies between steps taken to manage and curate research data can potentially reduce the extent to which 
these data may be combined and used as part of more complex research inquiries6. A potential consequence of this is 
reduced accuracy in meta-analyses as researchers are unable to analyze all potential datasets for inclusion in their 
study7. A lack of uptake of standards coupled with inconsistent quality of metadata can render analyses of 
epidemiological research data problematic8. Given that metadata are key to the research process, there is a need to 
develop and integrate metadata quality assessment into the daily routines of stakeholders in epidemiological and 
public health research.   
The aim of this work was to review different methods of metadata quality assessment and improve understanding of 
current practices in epidemiological and public health research. This study has four objectives: a) describe the 
current state of the art in metadata quality assessment of epidemiological and public health research data; b) identify 
key relevant metadata quality assessment dimensions; c) create a novel framework for assessing metadata quality for 
epidemiology/public health research data; and d) evaluate framework using test cases and engaging with 
stakeholders. 
 
 
  
Methods 
Literature review of biomedical and computer science databases 
We performed a literature review in July 2014 using cross-disciplinary databases to identify literature focusing on 
the assessment of biomedical metadata quality. The aim was to establish the current state of art and identify which 
formalized techniques are available to guide the assessment. We used the following biomedical and computer 
science databases, ACM Digital Library, BioMed Central, CINAHL Plus, Cochrane Library, EMBASE, Lecture 
Notes in Computer Science, JSTOR, PubMed, SCOPUS and Web of Science. The range of databases chosen 
included some not specific to public health and epidemiology to help capture literature which may be categorized 
into other fields of research such as librarianship or archive management. We included Google and Google Scholar 
to identify gray literature and reports. We also used forward citation tracking9 to systematically check through 
reference lists to help source other literature. 
To be included in the review, the literature had to available in English and be accessible openly or through use of 
institutional login. The manuscript had to describe clearly the method used to assess metadata and ideally provide 
examples of where the method has been applied. The searches were not restricted in any way in terms of publication 
date, format or location. In the review we recorded: a) title; b) aim; c) conclusion; d) method of quality assessment – 
a brief description of the approach to quality evaluation; and e) identified metadata quality dimensions. We used the 
following search terms: ‘epidemiology’, ‘metadata’, ‘metadata quality assessment’, ‘metadata quality dimensions’, 
‘metadata quality evaluation’, ‘public health’, ‘public health and epidemiology’, ‘quality assessment’, ‘quality 
evaluation’.  
Online stakeholder survey 
We collected qualitative data on how metadata are currently handled across the research data lifecycle and by 
whom. We targeted the online survey at stakeholders using epidemiological and public health metadata. We invited 
stakeholders to share the perceived challenges associated with creating, using and assessing metadata and indicate 
which quality dimensions were of importance to biomedical metadata. We also wanted to identify how metadata are 
currently assessed in public health and epidemiological research settings.    
The online survey ran for four months between November 2014 and February 2015 with a set of reminder emails 
sent two weeks before the survey was due to close. The survey had five sections: demographics, metadata, tools and 
technologies, metadata usability, and quality assessment. In the tools and technologies section, the list of metadata 
standards was partially based on a list from the Digital Curation Centre’s website10. Within the context of 
epidemiological and public health research, participants were asked to: a) indicate the technologies, tools and 
frequency of usage of metadata, b) identify and rank by importance key metadata usability dimensions, c) identify 
metadata quality assessment dimensions, and d) describe the main barriers in assessing metadata quality. We chose 
the themes and questions of our survey based on a combination of the review findings and current understanding of 
the role of metadata in epidemiological and public health research.  
The survey was designed and developed using Research Electronic Data Capture11 (REDCap) version 5.7.5, a web-
based data capture tool enabling development of survey instruments and collection of data in a secure environment. 
We included open-ended questions in the survey to facilitate the capture of qualitative data12. 
Framework definition and evaluation 
To analyze the qualitative results, we adopted a hermeneutic approach; grounded theory was applied and the themes 
were collated inductively and iteratively. The initial high level metadata quality assessment framework consisted of 
four sections: a) general information; b) tools and technologies; c) usability; and d) management and curation. 
We evaluated the framework in two steps. Firstly, by applying it to the metadata from three established cohort 
studies as test cases – the Millennium Cohort Study13 (MCS), Midlife in the United States14 (MIDUS) and Danish 
National Birth Cohort15 (DNBC) studies. In doing so, we were able to test how fit for purpose the high level 
framework was and identify its strengths, weaknesses, and areas of improvement. We iteratively revised the created 
framework based on results from the evaluation process.  Secondly, we engaged with stakeholders in 
epidemiological and public health research. This helped us to identify further areas of improvement and consider 
potential implications associated with implementing the framework into stakeholders’ daily routines.  
 
 
  
Results  
Literature review 
The literature review identified 11 studies16-26 and nine dimensions of quality. These included accessibility, 
accuracy/correctness, completeness/totality, conformance, interoperability, consistency, frequency, timeliness, and 
meta-metadata. The most commonly occurring dimension was completeness/totality with all studies incorporating 
this dimension. The review also identified several studies16, 21, 22, 25 that had divided their indicators of quality 
according to different criteria, such as structure21. In another study23, a series of logic rules categories had been used. 
These were: a) rules of inclusion; b) rules of imposition; and c) rules of restriction. In two studies19, 20, simple Dublin 
Core27 elements had been incorporated into the method of quality assessment. We did not identify any studies 
specifically aimed for epidemiological and public health data. 
Online stakeholder survey 
96 individuals globally submitted data using the survey; most of whom indicated they were employed by a 
university and located in Europe. The most commonly indicated role in public health and epidemiology was “Data 
User”. Most of the respondents used metadata in the analysis stage while the fewest respondents used metadata in 
the data destruction phase. Regarding the granularity of the metadata, ‘Research study level’ was most popular 
followed by ‘Variable level’. The most commonly selected type of metadata was descriptive with a total of 37 votes 
followed by administrative with 30. Results also show, of those that submitted data, the most common format of 
metadata was PDF(s) with 27; the least commonly indicated was the Resource Description Framework28 (RDF).  
The perceived barriers to creating and/or using metadata can be categorized into the following: a) awareness of the 
issue of metadata quality and requiring the training and guidance to address these issues; b) inconsistencies in the 
formatting of metadata; c) inadequate tool availability which limited the ability to create research artefacts such as 
data dictionaries, and ability to extract metadata from older, previous versions of software; d) a lack of metadata 
quality standards; and e) inadequate resource availability, in terms of finances and time. 
Of those who submitted data, most respondents, 46%, selected tools and technologies for use based on ‘standard 
practice’. The clinical terminology most respondents had utilized was the International Classification of Diseases29 
followed by Medical Subject Headings30. The perceived difficulties when using clinical terminologies included: a) a 
lack of medical knowledge increasing the time taken to understand the terminology before use; and b) ease of use – 
the volume and complexity of clinical terminologies plus the potential for inaccurate clinical coding can sometimes 
render clinical terminologies difficult to use.  
The most commonly used metadata standard by the respondents was the Data Documentation Initiative 231 
(Codebook) followed by Data Documentation Initiative 332 (Lifecycle). A total of 11 people indicated that they used 
metadata catalogues to help improve the discoverability of their research. Of those who shared their experiences of 
using catalogues to improve discoverability, one of the challenges faced was the catalogue not being fit for use. The 
majority of those who submitted data, 20, viewed the metadata being available in an open access repository as being 
essential to usability whilst 17 people viewed being the metadata being standards-based as extremely important.   
Perceived challenges respondents associated with assessing metadata quality in epidemiological and public health 
research can be categorized as follows.  Firstly, there was felt to be a lack of guidance and awareness of metadata 
quality assessment. Several participants commented on the lack of guidance to assist quality assessment with one 
respondent commenting that one of the problems is identifying, “…the best way to determine quality” while another 
wrote, “I haven’t thought about this”. Secondly, there was a lack of knowledge - a total of three people commented 
on use of domain-specific terminology impacting how well they understood the metadata; for example, one 
respondent commented on a “lack of experience and knowledge of the area”. Thirdly, respondents highlighted issues 
with knowing what software and other such tools were available to assist with quality assessments, and how to 
access these. Finally, the need to find the time needed to assess metadata quality was also identified33.  
‘Accuracy’ or the correctness of the metadata was deemed by respondents to be the most important metadata quality 
dimension. The least important quality dimension was ‘Meta-metadata’ with one respondent commenting, “before 
meta metadata let’s get metadata clear and well understood” (Table 1). 
 
 
  
Table 1. Dimensions of metadata quality for public health and epidemiological data as identified by the international 
stakeholder survey. 
Dimensions of metadata quality Responses 
N Percent CI 
Accuracy (correctness of the metadata)	 35	 14.9%	 10-20	
Accessibility (extent to which the metadata can be accessed) 34 14.5% 10-20 
Discoverability (how visible the metadata are - can it be easily found) 33 14.0% 10-19 
Appropriateness (extent to which the metadata are relevant) 24 10.2% 7-15 
Comprehensiveness (extent to which the metadata are complete) 24 10.2% 7-15 
Interoperability (extent to which metadata can be exchanged and used 
without problems) 
21 8.9% 6-13 
Timeliness (is the metadata current, inclusion of temporal information) 20 8.5% 5-13 
Versionability (extent to which a new version may be easily created)	 18	 7.7%	 5-12	
Extendibility (extent to which the metadata may be easily extended) 14 6.0% 3-10 
Meta-metadata (metadata about the metadata) 10 4.3% 2-8 
Other 2 0.9% 0-3 
Total 235 100.0%  
 
Results of the survey show that most people, 19 out of the 37 who provided a response, sometimes assess the quality 
of the metadata they routinely handled; whilst, eight people never do so. Results also showed only one person out of 
the 28 who provided a response indicated they used some kind of metadata assessment criteria; this was a built-in 
diagnostics tool as part of a metadata editor.  
Framework definition 
We created a high-level metadata quality assessment framework for use in epidemiological and public health 
research settings.  
The framework is composed of four sections: a) general information – to assess provision of the types, formats and 
granularity of the metadata available; b) tools and technologies – to assess the structure, application of clinical 
terminologies, indexing in catalogues, and use of Semantic Web technologies; c) usability – to assess presence in 
repositories, application of metadata standards, and provision of cross-walks or other semantic mappings; and d) 
management and curation- this refers to how the metadata were created and provision of and access to other 
metadata versions. Each section has three parts: 1) area of the framework; 2) associated quality dimensions; and 3) 
headings. Headings can have a basis in more than one quality dimension and the quality dimensions can be linked to 
more than one model (many-to-many relationships).  
In the ‘General information’ section, completeness refers to how comprehensive the metadata are while granularity 
looks at the level at which the metadata are available, e.g. research study level. The types of metadata includes, 
administrative, descriptive, microdata and semantic. The formats include PDF, Spreadsheet, Word-processed 
document, XML, RDF and HTML. In having access to metadata in different formats, the discoverability and 
accessibility of research data may be potentially enhanced. Metadata provided in RDF for example, can be published 
on the World Wide Web and its inherent scalability can be harnessed facilitating the integration of multiple disparate 
resources in support of clinical research34, 35.  
In the ‘Tools and technologies’ section, accuracy refers to the use of clinical terminologies and in particular the 
provision of codes and category lists. Specifically, it suggests stakeholders look at the way in which the process of 
using clinical terminologies to encode clinical information is described. Structure refers to how the metadata are 
presented; for example, sweep-level metadata may be presented in tables with downloadable data dictionaries. 
Access to clearly structured and unambiguous metadata can help stakeholders to navigate through the metadata more 
easily. Accessibility can also be enhanced by including metadata in public facing, searchable catalogues such as the 
CALIBER portal36. Portals and catalogues can provide searchable, and where possible downloadable, records of 
metadata from different epidemiological and public health studies. The use of Semantic Web technologies such as 
biomedical ontologies can potentially enhance the interoperability, extendibility and discoverability of research data. 
Additionally, by using mechanisms such eXtensible Markup Language (XML), there is the potential to create newer 
versions of the metadata whilst referencing previous versions; an example of where this is possible is using the Data 
Documentation Initiative Lifecycle32 metadata standard.  
  
In the ‘Usability’ section, standards can refer to metadata standards such as Minimum Information for Biological 
and Biomedical Investigations37 (MIBBI) or exchange standards such as Health Level Severn38 (HL7). Cross walks 
refers to mappings between metadata standards such as Data Documentation Initiative 231 to Data Documentation 
Initiative 332. In having cross walks between metadata standards, the metadata’s interoperability could potentially be 
enhanced. Cross walks also refers to mappings between clinical terminologies such as MeSH and ICD. In providing 
these details, researchers wanting to run queries using multiple terminologies from disparate datasets could 
potentially identify which clinical codes are equivalent in support of clinical cohort phenotyping for example. The 
use of repositories acts as a mechanism to enhance discoverability and provide meta-metadata. Meta-metadata are 
metadata about the metadata; for example, date when metadata were created, the version number and by whom. 
In the ‘Management and curation’ section, inclusion of the ‘dates’ and ‘versions’ headings encourage stakeholders 
to look at the meta-metadata and encourages them to assess how timely the metadata are. Provision of this meta-
metadata also helps to support version control, and scope for extension. (Figure 1) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Sections of the high level quality assessment framework for metadata in epidemiological and public health 
research settings 
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Framework evaluation 
We firstly evaluated the high level framework by applying it to three test cases: Millennium Cohort Study (MCS), 
Midlife in the United States (MIDUS), and the Danish National Birth Cohort (DNBC) study through an iterative 
process. After each iteration we revised the framework and re-applied it to the test-case studies.  
When we applied the first version of the framework to the MCS study metadata; we noted that the ‘General 
information’ section did not include a mechanism to specify which artefacts were reviewed and where these can be 
found. To work around this, this information was placed under the ‘Missing or incomplete metadata’ section where 
the completeness of the metadata were reviewed. Though not ideal, we were able to record the artefacts reviewed 
and describe any difficulties experienced. In the second version, we added mechanisms to specify which documents 
were reviewed and in doing so, were able to record our findings more clearly. We also added sections for variable 
descriptions, online data visualization tools, links to other studies, sweeps or publications, and an ‘other’ section. By 
making these adjustments, we were able to record our findings more clearly. For example, we were able to record 
links to publications at sweep and study level for the MIDUS study, and links to all four sweeps, NCI indexed 
publications and a list of theses using DNBC data for the DNBC study. 
In the ‘Tools and technologies section of the first version of framework, we found that assessment findings could be 
recorded in different places due to the inherent links between headings and quality dimensions. For example, clinical 
terminologies can be structured using ontologies. Recording this information using the first version of the 
framework can use the ‘Presence of clinical terminologies’, ‘Application of Semantic Web technologies’, and 
‘Method of application and reason(s) for use’ headings. We designed the framework to guide stakeholders when 
assessing metadata quality and not be a ‘question and answer’ style exercise; stakeholders are encouraged to record 
findings wherever they deem is most appropriate. In the second version, by adding the heading, ‘Presence of code(s) 
and category(ies)’ this enabled us to record the variable coding conventions for the MIDUS study, and the locations 
of the codebooks for interviews for the DNBC study. By merging the catalogues and repositories sections together, 
we were able to group this information together and record where metadata had been sourced.  
In the ‘Usability’ section of the first version of the framework, we identified the need for a mechanism to record 
details of any caveats potentially impacting use of catalogues or repositories. Having access to this kind of 
information could help stakeholders better understand how research data could be accessed. We also identified the 
need to add a mechanism to record provision of the underlying metadata model; access to this kind of information 
could potentially enhance scope for metadata exchange – interoperability. We also recognized the potential for 
repetition in the first version of the framework by having separate ‘repositories’ and ‘catalogue’ headings. Hence in 
the second version, these headings were combined to reduce the potential for redundancies in the framework. In the 
second version we also added a mechanism to record metadata models. In making this change, we could record 
findings relating to how potentially interoperable the metadata are. For example, we could record that metadata for 
the MIDUS study were compliant with the, DDI, DC, MARC21 and Datacite metadata standards; metadata for the 
DNBC study were compliant with the DDI metadata standard.     
Lastly, having applied the first version of the framework to the first test case, we decided that the ‘Management and 
curation’ section should be divided into two sections: a) the creation and version information of the metadata being 
reviewed; and b) the creation and version information of the review itself. In differentiating between these two types 
of meta-metadata, stakeholders can potentially see how up-to-date the metadata are, and how current the quality 
assessment is. Having implemented these changes, using the second version of the framework we were able to 
record the meta-metadata of the quality assessment itself and have a basic versioning system of the assessments 
using version numbers and dates. In having this meta-metadata, there is the potential to monitor metadata quality 
across assessments, and potentially identify any necessary corrective action. 
Stakeholder engagement 
We engaged with three stakeholders to obtain feedback and identify any further areas of refinement. It was noted by 
one stakeholder that the framework does not have a column for assessment findings. The framework should be 
viewed as a reference document and an altered version of the framework with a ‘findings’ column should be used 
when assessing metadata quality. The suggestion was also made to include potential answers for the headings; for 
example, for the heading, ‘Indexing in catalogues/repositories’ potential answers could include INDEPTH Data 
Repository iSHARE239 and IPUMS40. It was also unclear to a stakeholder which clinical terminologies were being 
referred to. The clinical terminologies heading was included in the framework to establish if clinical terminologies 
have been used and the version e.g. ICD 10. This could potentially support stakeholders in tracking any version 
  
changes e.g. ICD 9 to 10 and how these changes were managed. There is also the possibility to better support 
stakeholders in identifying any potential harmonisation work to enable continued use of these encoded research data. 
Therefore, we refined this area of the framework to better guide stakeholders when assessing metadata. Furthermore, 
a comment was made that finding metadata at a range of levels complete with links to publications is unrealistic and 
increased support for stakeholders is needed when assessing metadata. Whilst we acknowledge that the framework 
may provide a somewhat idealistic expectation of metadata, the framework was designed to provide a non-
exhaustive list of headings to guide stakeholders. Context needs to be taken into consideration when assessing 
metadata quality as the granularity of metadata available may differ across the epidemiological and public health 
research domains. 
Discussion  
Literature review 
In using a mix of computer science and biomedical databases we identified a range of literature for potential 
inclusion in the review.  This was advantageous as in areas such as e-libraries and archive management, a lot of 
work had been done on metadata quality assessment and we were able to identify literature which, though not 
included in the review, provided useful contextual information. The literature review did not identify a method of 
metadata quality assessment designed specifically for use in an epidemiological and public health research setting. 
However, given the methods identified were from research domains other than epidemiology and public health, the 
extent to which lessons learnt may be applied to epidemiological and public health research is inherently limited. 
This is because the methods identified lacked quality dimensions such as ‘Extendibility’; potentially as this level of 
functionality was not required. Nevertheless, the review did identify quality dimensions, such as accuracy and 
accessibility, which at a high level are applicable to biomedical metadata. By combining quality dimensions such as 
these, with the dimensions we identified through the survey as important to biomedical metadata, such as 
‘Discoverability’, we were able to produce a novel list of biomedical metadata quality dimensions.    
Online stakeholder survey 
Most of the respondents indicated they used descriptive metadata to some extent. This outcome could potentially 
reflect the respondents’ roles in public health and epidemiology research and by extension their daily routines. 
Given that most of the respondents were data users employed by a university, and that metadata often accompanies 
epidemiological and public health research datasets, this could explain why descriptive metadata was the most 
popular. Results also showed that PDF was the most commonly handled format of metadata. This could be because 
organizations such as the Health & Social Care Information Centre provide the metadata for certain datasets as PDF 
documents. Given the proclivity of researchers to use these clinical data for research purposes, familiarity with this 
type of metadata is ameliorated. 
The identified barriers to creating and/or using metadata in epidemiological and public health research could 
potentially be explained through a previous lack of focus on the importance of metadata; possibly contributing to the 
subsequent lack of training and support. Knowledge of the role of metadata across the stages of research data 
lifecycle is increasing as is familiarity with metadata standards. Stakeholders have a tendency to refer to best 
practice guidelines to inform the undertaking of research. This could explain why most respondents selected tools 
and technologies based on standard practice. This is important to the implementation and use of our novel 
framework in epidemiological and public health research as, integrating regular metadata quality assessments into 
work routines through inclusion in best practice guidelines, is a future goal of this work.  
Regarding use of clinical terminologies, ICD was initially developed to encode clinical information for death 
certificates; whilst terminologies such as Read Codes and SNOMED CT were designed to encode information for 
clinical care. Both sources of data are routinely harnessed in public health and epidemiology research for secondary 
use but the current popularity of using ICD to encode clinical information could explain our survey findings. Of 
those who shared challenges experienced with using clinical terminologies, most respondents were data users, only 
nine were ‘clinician/clinical advisor’. This could potentially explain why problems such as a lack of medical 
knowledge and ease of use were experienced. Having medical knowledge can potentially help when undertaking 
tasks such as clinical phenotyping, and often researchers work in multidisciplinary teams including clinicians to 
determine which clinical codes are needed.  
Issues associated with the use of metadata catalogues could possibly be attributed to the lack of academic incentives 
to use this kind of catalogue coupled with limited knowledge of the existence of such platforms. Metadata 
  
catalogues can enhance the discoverability of research data and support stakeholders in identifying and 
characterizing data without accessing the research data directly. Of those who submitted additional aspects of 
importance for metadata usability, suggestions included having multiple formats of the metadata and semantic 
mappings. As metadata standards such as DDI are being continuously developed, semantic mappings or cross-walks 
between the different schemas are needed to support interoperability.  
There are a number of strengths and weaknesses of the online survey. In using an online survey, we were able to 
contact and request participation from stakeholders globally within a relatively short period of time. We also 
requested the invitational email be forwarded to any interested parties potentially missed. However, this approach to 
recruitment rendered it infeasible to calculate a response rate and track to whom the survey was sent. There was also 
the potential for incorrect email addresses to limit the extent to which the invitational email was circulated.  
Following the cross-disciplinary literature review and comprehensive online stakeholder survey, we identified a lack 
of formalized quality assessment methods for metadata in epidemiological and public health research settings. 
Through the literature review, we did not identify a framework specifically geared to epidemiological and public 
health research datasets and most approaches originated from information studies or other scientific domains. The 
stakeholder survey revealed that this lack of standardized methods for assessing metadata quality was acting as a 
barrier to assessing quality of metadata in epidemiological datasets in a systematic manner.  Our novel framework is 
the first of its kind aimed specifically for use in epidemiological and public health research settings.  
Framework 
Our results show the five dimensions of most importance are: accuracy, accessibility, discoverability, 
appropriateness, and comprehensiveness.  
To assess accuracy, stakeholders could establish how timely the metadata are and when the metadata were updated. 
To assess accessibility and discoverability, stakeholders could determine how well structured the metadata are and if 
they are available through a catalogue. Stakeholders are advised to establish whether encoding standards such as 
ICD and/or exchange standards such as HL7 have been utilized. It is also possible to assess how well knowledge has 
been managed through effective application of biomedical ontologies and whether these can be viewed. To assess 
appropriateness, stakeholders could determine whether necessary details have been provided to enable other 
stakeholders to understand and potentially reuse the research data. More specially, stakeholders are advised to 
determine how comprehensible the metadata are at different levels; for example, stakeholders could assess whether 
sufficient descriptions have been provided of variables to enable potential secondary researchers to characterize the 
dataset. Comprehensiveness could be determined by establishing how encompassing the metadata are and if the 
metadata contain gaps. For example, stakeholders could assess whether details of changes made to a sweep of data 
have been communicated effectively.  
However, the definitions and recommendations presented are generic and potentially applicable across all aspects of 
public health and epidemiology research. For example, accuracy of metadata associated with electronic health 
records may not necessarily be the same as that of metadata associated with cohort studies; nor is the approach to 
quantifying accuracy of the metadata and the mechanism through which it may be tested. The difficulty remains in 
being able to deliver pragmatic quality dimensions whilst being mindful of the intricacies of the sub-domains of 
epidemiological and public health research.   
Framework evaluation 
Metadata standards such as DDI are commonly applied to metadata indexed in repositories/catalogues. Though this 
is beneficial as the metadata elements are standardised, and there is scope to download the DDI compliant XML, 
this does emphasize the need for increased application of metadata standards across epidemiological and public 
health research regardless of whether metadata are indexed. However, this in itself presents challenges such as 
having access to the necessary resources and assigning responsibility for ongoing maintenance.  
Furthermore, for each test case, we were unable to find the method of application and reason(s) for use of Semantic 
Web Technologies; potentially as it does not seem commonplace to provide this kind of information. We had 
decided to include this section in the framework as we wanted to see if the method of application is linked in some 
way to the quality of the metadata. As stakeholders are able to customize the framework to suit local needs, we 
decided to keep this section as it is not a mandatory field in the assessment.  
A potential weakness of the framework is that given multiple research artefacts may need to be sourced before 
quality can be assessed, the question of how much metadata is needed is raised. Another potential weakness of our 
  
framework is the lack of quantitative analysis; all assessments are manual/qualitative which are inherently 
subjective.  
Conclusions  
The use of clinical data for research purposes to better inform the development of clinical policy and practice is 
critical in public health and epidemiological research. One of the main challenges in assessing quality in 
epidemiological and public health research is a lack of awareness of the issue of poor quality metadata and the 
potential implications this can have on research data discoverability. Improved awareness of the issue of metadata 
quality is needed, as are mechanisms to integrate metadata quality assessments into daily routines of stakeholders in 
epidemiological and public health research.  
We created and evaluated a novel framework as a platform-independent method of assessing metadata quality, with 
the goal of improving metadata in epidemiological and public health research settings and enhancing the potential 
for data discovery and reuse in the context of epidemiological and public health research studies. 
Our next steps include engaging with stakeholders to establish a set of requirements for a series of computational 
metrics. Our short term goal is to identify a set of quantitative measures of quality to compliment the framework. 
The longer term goal is to use these metrics to increase objectivity and automate/quicken the overall assessment 
process. 
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